Cargando…
Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer
BACKGROUND: Karyopherin alpha 2 (KPNA2), a member of the karyopherin family, plays a vital role in carcinogenesis. Yet its role in colon cancer is poorly characterized. We sought to clarify the clinical significance of its dysregulated expression in human colon tumor specimens. METHODS: We evaluated...
Autores principales: | Zhang, Yu, Zhang, Meng, Yu, Fudong, Lu, Su, Sun, Huimin, Tang, Huamei, Peng, Zhihai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665890/ https://www.ncbi.nlm.nih.gov/pubmed/26626145 http://dx.doi.org/10.1186/s13046-015-0261-3 |
Ejemplares similares
-
Karyopherin alpha 2 expression is a novel diagnostic and prognostic factor for colorectal cancer
por: Yu, Lei, et al.
Publicado: (2017) -
Karyopherin Alpha Proteins Regulate Oligodendrocyte Differentiation
por: Laitman, Benjamin M., et al.
Publicado: (2017) -
Expression of Karyopherin Alpha 2 and Karyopherin Beta 1 Correlate with Poor Prognosis in Gastric Cancer
por: Ohhara, Yoshihito, et al.
Publicado: (2022) -
Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer
por: Zhang, Meng, et al.
Publicado: (2015) -
PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy
por: Chen, Jian, et al.
Publicado: (2014)